Low vitamin D levels in newborns could increase their future risk of MS, according to new research.
Scientists found that children born with very low levels of vitamin D were more likely to develop MS in later life.
One of our strategic goals is to give people with MS more certainty about their future. To help achieve this, researchers are investigating the biomarkers of MS.
What’s a biomarker?
Biological markers (or biomarkers) are detectable changes in the body. They can be anything from molecules in your blood to visible physical changes.
Running has made the news recently with an animal study that looks at the impact it has on the brain. What did it show? We take a look behind the headlines.
Not always getting the care that I’ve needed has been pretty hard at times, so I was really interested in the results of the My MS, My Needs survey.
The survey aimed to find out more about access to treatment, care and support among people with MS.
It’s never been easier to access information about health issues. With science journals becoming more freely available and medical research receiving more media attention than ever, how can we know which research to trust?
Fatigue, vision problems, trouble walking – the symptoms of MS are varied and unpredictable. But what about pain?
A team of researchers from King’s College London thought it was about time we understood more about the effects of pain on people affected by MS.
As reported in the news today, there have been new results published on autologous haematopoietic stem cell transplantation (AHSCT), describing the long-term effects of stem cell transplantation.
We spoke with leading expert in the field of stem cells and MS research, Dr Paolo Muraro from Imperial College London, about making sense of the study and what it may mean for people with MS.
Fasting-mimicking diets (FMDs) have hit the headlines with new research discussing their potential for people with MS. But what did the study show? We take a look behind the headlines.